Cross-sectional study for COVID-19-related mortality predictors in a Brazilian state-wide landscape: the role of demographic factors, symptoms and comorbiditiesArticle Published on 2022-10-172022-11-15 Journal: BMJ Open [Category] 진단, [키워드] 95% CI Analysis association cardiac epidemiology Clinical severity Comorbidity COVID-19 COVID-19 pandemic criteria criterion cross-sectional study dataset death demographic characteristics Demographic factors diabete diabetes & diagnosed disease disorder Effects electronic medical record endocrinology Epidemiology evaluate Factor health system healthcare highlight hospitalisation hospitalised ICU implementation increased mortality information Intervention kidney kidney & Kidney disease majority measure mitigate Mortality multicollinearity non-hospitalised non-ICU non-ICU patient occurred Patient patients patients older predictor Prevent public health public health. reverse transcription-PCR secondary outcome selected severity Sex state suffered Symptom Urinary tract urinary tract disorders virus [DOI] 10.1136/bmjopen-2021-056801 PMC 바로가기
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and WalesArticle Published on 2022-10-152022-11-16 Journal: Lancet (London, England) [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI adjusted age analyses analysis Analysis aRR association B.1.1.529 benefit BNT162b2 booster booster dose Booster vaccine calculated ChAdOx1 nCoV-19 Chronic kidney disease Committee Comorbidities Comorbidity conducted core covariates COVID-19 COVID-19 hospitalisation COVID-19 infection COVID-19 therapeutics COVID-19 vaccination current death dominant Edinburgh England event group Health health condition high risk hospitalisation identify immunisation Immunosuppressant increased risk individual initial Innovation Ireland male Medical Research Council meta-analyses Moderna mortality data mRNA-1273 Multimorbidity National of BNT162b2 offer older adult outcome outcomes Oxford-AstraZeneca per 1000 person-year per 1000 person-years Pfizer-BioNTech Poisson regression model primary care prospective cohort prospective cohort study rate ratio receiving reduced reduced risk remained risk risk factor RT-PCR testing SARS-COV-2 infection Scottish severe COVID-19 Sex those with comorbidity university vaccination Vaccine vaccine dose vaccine group variant [DOI] 10.1016/S0140-6736(22)01656-7 PMC 바로가기
Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in EnglandArticle Published on 2022-10-132022-11-16 Journal: Nature Communications [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI confounders country COVID-19 case death dominant variant England hazard hospital Hospital admission hospitalisation Infection investigated large cohort mortality risk multivariable omicron outcome public health regression models risk SARS-CoV-2 stratified variant variant of SARS-CoV-2 [DOI] 10.1038/s41467-022-33740-9 PMC 바로가기
Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational studyArticle Published on 2022-10-082022-11-15 Journal: Lancet (London, England) [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] Abstract Admission age ambulatory patient Analysis Antiviral antiviral drug authority B.1.1.529 Case-control Charlson Comorbidity Index China Chinese clinical effectiveness Cohort Community Control COVID-19 outpatient Cox regression death Diagnosis diagnosis of SARS-CoV-2 Disease progression dominant Effectiveness glomerular filtration rate hazard Hong Kong hospitalisation HRs identify in both group In-hospital In-hospital death Infection intensive care Invasive mechanical ventilation less Logistic regression lower risk material median molnupiravir Mortality Nirmatrelvir non-hospitalised Odds ratio Older older patients outcome Outpatient Patient patients with COVID-19 primary analysis reduced risk Region Registered retrospective cohort risk Ritonavir SARS-CoV-2 SARS-COV-2 infection sensitivity analysis Sex supported the SARS-CoV-2 translation used data vaccination variant [DOI] 10.1016/S0140-6736(22)01586-0 PMC 바로가기
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?Article Published on 2022-10-062022-11-15 Journal: The European Respiratory Journal [Category] COVID19(2023년), SARS, 진단, [키워드] activity acute respiratory syndrome Brain Care clinician collected comparable conducted consequence coronavirus coronavirus disease COVID-19 death demographic data determine diagnose diagnosed Disease progression echocardiographic effective Escalation functional Healthcare provider hospitalisation incidence incidence of COVID-19 Infection Italian Italian population Italy less management material measure Mortality mortality rates multicentre outbreak outcome PAH Patient patients patients with COVID-19 peptide potential risk public health pulmonary arterial hypertension reduction in remote monitoring resulting risk SARS-CoV-2 Treatment World Health Organization [DOI] 10.1183/13993003.02276-2021 PMC 바로가기
Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South AfricaArticle Published on 2022-10-042022-11-16 Journal: Nature Communications [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI clinical Clinical severity COVID-19 COVID-19 case Delta delta variant diagnosed Factor hospitalisation hospitalised individual individuals Infection infections Laboratory Lineage multivariable logistic regression National omicron outcome PCR assay reduced risk S-gene SARS-CoV-2 severe disease severity South Africa TaqPath [DOI] 10.1038/s41467-022-33614-0 PMC 바로가기
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the worldArticle Published on 2022-10-032022-11-16 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome appear approval approved coronavirus coronavirus disease country COVID-19 COVID-19 outbreak COVID-19 vaccine death deaths delta variant disease disease severity distribution drug Effect effective Effectiveness effort Emergency use fatality health emergency health system healthcare hospitalisation Hospitalization individual Omicron variant Omicron variants outbreak pandemic Prevent PROTECT provided reduced remained researcher SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants severe disease severity Spread Uncertainty vaccination Vaccine Vaccine development vaccine platform Vaccines variant Variant of concern. World Health Organisation [DOI] 10.3389/fimmu.2022.961198 PMC 바로가기
Neuropathological findings in fatal COVID-19 and their associated neurological clinical manifestationsArticle Published on 2022-10-012022-11-16 Journal: Pathology [Category] COVID19(2023년), SARS, 치료기술, [키워드] Autopsy Brain calculated case sery CD8 Cell Central nervous system clinical clinical manifestation clinical manifestations correlated correlation COVID-19 described Encephalopathy fatal COVID-19 FIVE highest hospitalisation hypoxic IL-6 illness duration intensive care lesion lesions macrophage activation syndrome microglial microthrombi Neuroinflammation neurological Neurological symptoms neuropathology. no correlation one patient onset of symptoms parameter pathology Patient patients performed Pituitary proportion qRT-PCR quantification retrospective SARS-CoV-2 RNA severe COVID-19 patient systemic inflammation T-cell activation Two patient Vascular [DOI] 10.1016/j.pathol.2022.03.006 PMC 바로가기
Risk of hospitalisation or death in households with a case of COVID-19 in England: an analysis using the HOSTED data setCase Reports Published on 2022-10-012023-07-10 Journal: Public health [Category] COVID19(2023년), [키워드] COVID-19 England hospitalisation HOSTED household contacts household transmission Mortality SARS-CoV-2 Secondary user service surveillance. [DOI] 10.1016/j.puhe.2022.07.013 PMC 바로가기 [Article Type] Case Reports
Methods for early characterisation of the severity and dynamics of SARS-CoV-2 variants: a population-based time series analysis in South AfricaArticle Published on 2022-10-012022-11-16 Journal: The Lancet. Microbe [Category] COVID19(2023년), SARS, 변종, [키워드] African age agency aggregate analyses Analysis assessment calculate case ascertainment characterisation Characteristics correlation coefficient COVID-19 data-driven death dependent on develop disease severity Effect epidemic wave epidemiological estimate fluctuation Government Hospital admission hospitalisation hospitalisations individual information interval laboratory data Metrics Older Omicron variant pathogen Population provide public health Public health responses reduced reduction in resource responses robust SARS-CoV-2 severity South South Africa Spread surveillance data variant VoC VOCs [DOI] 10.1016/S2666-5247(22)00182-3 PMC 바로가기